WO2010127395A1 - Système de distribution d'agent - Google Patents

Système de distribution d'agent Download PDF

Info

Publication number
WO2010127395A1
WO2010127395A1 PCT/AU2010/000518 AU2010000518W WO2010127395A1 WO 2010127395 A1 WO2010127395 A1 WO 2010127395A1 AU 2010000518 W AU2010000518 W AU 2010000518W WO 2010127395 A1 WO2010127395 A1 WO 2010127395A1
Authority
WO
WIPO (PCT)
Prior art keywords
cannula
agent
receptacle
patient
disc
Prior art date
Application number
PCT/AU2010/000518
Other languages
English (en)
Inventor
Ashish D. Diwan
Divya Diwan
Original Assignee
Cellixe Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellixe Pty Ltd filed Critical Cellixe Pty Ltd
Publication of WO2010127395A1 publication Critical patent/WO2010127395A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
    • A61B17/1662—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body
    • A61B17/1671—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body for the spine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
    • A61B17/1642—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for producing a curved bore
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3472—Trocars; Puncturing needles for bones, e.g. intraosseus injections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/70—Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant
    • A61B17/7061—Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant for stabilising vertebrae or discs by improving the condition of their tissues, e.g. using implanted medication or fluid exchange
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
    • A61B17/8802—Equipment for handling bone cement or other fluid fillers
    • A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
    • A61B17/8811—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by the introducer tip, i.e. the part inserted into or onto the bone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
    • A61B17/8802—Equipment for handling bone cement or other fluid fillers
    • A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
    • A61B17/8816—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by the conduit, e.g. tube, along which fluid flows into the body or by conduit connections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
    • A61B17/8802—Equipment for handling bone cement or other fluid fillers
    • A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
    • A61B17/8819—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by the introducer proximal part, e.g. cannula handle, or by parts which are inserted inside each other, e.g. stylet and cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M25/0075—Valve means
    • A61M2025/0076—Unidirectional valves

Definitions

  • This invention relates, generally, to the treatment of degenerate, diseased or damaged body tissue and, more particularly, to an agent delivery system, a method of delivering an agent to a site in a patient's body and to components for the administration of an agent to a site in a patient's body tissue where the tissue pressure is such that special arrangements are required at the point of egress of the agent.
  • a major cause of joint pain in a person arises due to degeneration, disease or damage of tissue at a bony interface in the person's body.
  • a typical example is the occurrence of back pain in a person due to degeneration, disease or damage to an intervertebral disc (referred to as a "degenerate disc") between two vertebrae in the person's spinal column.
  • Such a degenerate disc may result in back pain, neck pain and/or referred pain in the person's arms or legs.
  • An intervertebral disc is an avascular structure that is viscoelastic in nature and consists of a central nucleus pulposus (referred to for brevity as the "nucleus”) and an outer annulus fibrosis (referred to for brevity as the "annulus”).
  • the nucleus performs a compressive load bearing function of the disc and the annulus serves a tensile function of the disc.
  • the nucleus and the annulus are both cellular in nature and injury, disease or degeneration due to senescence of the cells can lead to changes in the physical characteristics of the disc which can result in the generation of pain in the person.
  • the disc is sandwiched between end plates of the vertebrae.
  • the end plates have been postulated to act as a diffusion barrier, the physiological alteration of which contributes to an altered metabolism and, hence, degeneration of the disc.
  • the present inventors have discovered that this is an over-simplification of a complex tissue interface and that the end plates are an active cell repository which have the potential for cell renewal and the supply of mature cells to the disc.
  • the inventors also believe that the apophyseal ring-vertebral bone junction in adults continues to replenish the cellular contents of the disc.
  • Morphogens, reagents or cells with the potential to activate and mobilise precursor cells or pre-cartilaginous cells can be made to proliferate, or mobilised and enhanced, in the area of the end plate-annulus-bone junction and the apophyseal ring. It therefore appears that the physiological attributes of the end plate are predominantly cellular functions. It is generally understood that the active ingredient necessary to encourage proliferation of precursor cells or pre-cartilaginous cells is expensive and wastage of such active ingredient is to be minimised. Also, techniques and equipment are required for delivering the active ingredient to the desired site in the patient's body in situations where tissue pressure can be significantly higher making egress of the active ingredient difficult.
  • an agent delivery system which includes a dispenser defining a reservoir and an outlet port in communication with the reservoir; a high density, immiscible, non-reactive, biocompatible displacement fluid contained within the reservoir; and a displacement device arranged in the reservoir for displacing the fluid through the outlet port of the dispenser.
  • the system may include a receptacle of the agent, the receptacle having a mounting formation for mounting the receptacle to the dispenser so that an interior of the receptacle is in communication with the outlet port of the dispenser.
  • the receptacle comprises a cannula with at least one discharge opening.
  • the cannula may be elongate having a side wall defining a plurality of axially spaced discharge openings. It will be appreciated that the tip of the cannula could also define an opening.
  • Each discharge opening may include an occluding device for inhibiting back flow of the agent into the interior of the cannula.
  • Each occluding device may be in the form of a one-way valve. Further, each of at least some of the openings may open out into a recessed region of the side wall of the cannula.
  • the cannula may be shaped and dimensioned to access a plurality of sites simultaneously.
  • the cannula may also be flexible to be able to be directed to a desired location in a patient's body.
  • the cannula may be shaped to facilitate periannular insertion, including trans-sacral epidural insertion, transforaminal epidural insertion and interlaminar periannular insertion.
  • the cannula may be shaped to facilitate insertion into the epidural space from one side to a contralateral side within the spinal canal close to the annulus whilst still in the epidural space and/or in the extra canal space in the periannular area.
  • the cannula may have radiological markers and be flexible to be able to be negotiated with minimum likelihood of damage to neighbouring blood vessels, the dura, or nerve tissue.
  • the system may include a reaming tool for forming a passage through bone at a site in the patient's body into which the receptacle is to be inserted.
  • the reaming tool may be insertable via a working cannula to the site and be manipulated through the bone to form the passage.
  • the reaming tool may be steerable.
  • a receptacle for delivering an agent to a site in a patient's body, the receptacle including an elongate body defining a lumen; at least one opening defined in the body through which the agent can be discharged; and an occluding device contained in the receptacle in register with the at least opening for closing off the at least one opening to inhibit back flow of the agent into the lumen of the body after being discharged through the at least one opening.
  • the body may have a mounting formation for mounting to a dispenser so that an interior of the body is in communication with an outlet port of the dispenser.
  • the body may comprise a cannula having a side wall defining a plurality of axially spaced discharge openings. It will be appreciated that each opening may have an occluding device associated with it. Each of at least some of the openings may open out into a recessed region of the side wall of the cannula.
  • the cannula may be shaped and dimensioned to access a plurality of sites simultaneously. Further, the cannula may be flexible to be able to be directed to a desired location in a patient's body.
  • a reaming tool for forming a passage in bone in a patient's body, the reaming tool including a reaming head; a pivot to which the reaming head is pivotally mounted; and a steering mechanism for steering the reaming head through body tissue and bone.
  • the reaming head may be omni-directionally pivotally mounted relative to the pivot.
  • a method of delivering an agent to a site in a patient's body comprising inserting a cannula into the site, the cannula containing a quantity of the agent to be delivered and the cannula being mounted on a dispensing device; and using a high density, immiscible, non-reactive, biocompatible displacement fluid contained within a reservoir of the dispensing device to discharge the agent from the cannula.
  • the dispensing device may be a syringe with a plunger displaceably arranged in the syringe.
  • the arrangement may be such that there is a sufficient volume of displacement fluid in the syringe so that, when the plunger has reached its maximum point of travel, the volume of displacement fluid has been displaced into the cannula to discharge substantially all the agent from the cannula.
  • the method may include inserting the cannula into the patient's body percutaneously.
  • the agent may be delivered minimally invasively.
  • the method may include forming a passage through tissue and bone in the patient's body to enable the cannula to be delivered to the site.
  • the method is intended particularly, but not necessarily exclusively, for treating at least one degenerate disc in the patient's body and the method may include forming a passage through the vertebra on at least one side of the disc to be treated and delivering the agent to an end plate of the vertebra.
  • the method may include delivering the agent to a number of vertebrae simultaneously.
  • the method may include inserting the cannula trans-sacrally.
  • the method may include manipulating the cannula about cartilaginous tissue in the patient's body.
  • the method is intended particularly, but not necessarily exclusively, for treating at least one degenerate disc in the patient's body and the method may include inserting the cannula periannularly adjacent the disc to be treated.
  • the periannular insertion of the cannula is selected from the group consisting of trans-sacral epidural insertion, transforaminal epidural insertion, interlaminar periannular insertion, negotiation of the cannula through the epidural space from one side to a contralateral side within the spinal canal close to an annulus of the disc and negotiation of the cannula in extra canal space in the periannular area.
  • Fig. 1 shows a schematic representation of a vertebral joint showing a pair of vertebrae sandwiching an intervertebral disc
  • Fig. 2 shows a schematic, sectional side view of an embodiment of an agent delivery system prior to use
  • Fig. 3 shows, on an enlarged scale, a schematic, sectional side view of a part of the system of Fig. 2 encircled by Circle 'A';
  • Fig. 4 shows a schematic, sectional side view of the agent delivery system in use
  • Fig. 5 shows, on an enlarged scale, a schematic, sectional side view of a part of the system of Fig. 4 encircled by Circle 1 B 1 ;
  • Fig. 6 shows a schematic, sectional side view of the agent delivery system after discharge of the agent into a site in a patient's body
  • Figs. 7a - 7d show, schematically an example of steps for forming a passage in a patient's vertebrae using an embodiment of a reaming tool
  • Fig. 8 shows, schematically, four different embodiments of receptacles for delivering an agent, in use
  • Fig. 9 shows, schematically, two further embodiments of a method of delivering an agent to a site in a patient's body
  • Fig. 10 shows a schematic side view of a distal part of a further embodiment of a cannula of the delivery system, in use;
  • Fig. 11 shows a schematic side view of a distal part of yet another embodiment of a cannula of the delivery system
  • Fig. 12 shows a schematic side view of a distal part of still a further embodiment of a cannula of the delivery system
  • Fig. 13 shows a side view of yet another cannula of the delivery system.
  • Fig. 14 shows a side view of a distal part of the cannula of Fig. 13.
  • FIG. 1 of the drawings a schematic representation of a vertebral joint is illustrated and is designated generally by the reference numeral 10.
  • the vertebral joint 10 comprises a first vertebra 12, a second vertebra 14 and an intervertebral disc 16 sandwiched between the vertebrae 12 and 14.
  • the disc 16 comprises an annulus fibrosis, or annulus, 18 surrounding a nucleus pulposus, or nucleus 20.
  • Each vertebra 12, 14 includes an end plate 22 which bears against the disc 16 and serves in regulating hydration of the disc 16.
  • An intervertebral disc 16 such as illustrated in Fig. 1 of the drawings, can degenerate due to a number of factors, including age, injury or other biological factors.
  • a consequence of a degenerate disc 16 is the generation of back and neck pain, this pain radiating to arms and legs of the patient's body. Changes to the disc resulting in the generation of change could arise from the following:
  • Remedies in the treatment of degenerate disc include removal of the entire disc and replacement thereof by a prosthetic disc, removal of the disc and fusion of the vertebrae, both of which are very invasive procedures resulting in major tissue trauma, and, more recently, removal of the nucleus 20 of the disc and replacement by a prosthetic nucleus.
  • the present inventors have determined that degenerate discs can also be treated therapeutically by the introduction of suitable active agents.
  • each end plate of the vertebrae is a repository for stem cells which can be used in regeneration of discal cells by the injection of suitable active agents.
  • a similar discovery has occurred in respect of the apophyseal ring-vertebral bone junction.
  • agents to be used includes, but is not limited to, the following:
  • an embodiment of a system for delivering an agent is designated generally by the reference number 30.
  • the system 30 includes a dispenser in the form of a syringe 32.
  • the syringe 32 defines a reservoir 34.
  • a displacement device in the form of a plunger 36 is displaceably mounted in the reservoir 34 for discharging an agent 38 received in the reservoir 34 through an outlet port 40 of the syringe 32.
  • a receptacle in the form of a cannula 42 is attachable to the outlet port 40 of the syringe 32 so that an interior 44 of the cannula 42 is in communication with the reservoir 34 of the syringe 32.
  • the system 30 includes a high density, immiscible non-reactive biocompatible displacement fluid 46 contained within the reservoir 34 of the syringe 32.
  • fluid is to be understood in a broad sense as any suitable fluent material and includes gels, etc.
  • the displacement fluid 46 is arranged in the reservoir between the outlet port
  • the volume of displacement fluid 46 arranged in the reservoir 34 of the syringe 32 is selected to approximate that of the volume of the interior 44 of the cannula 42.
  • the displacement fluid 46 is selected to have sufficiently fluent properties to be able to be displaced out of the reservoir 34 and also to be biocompatible. Importantly, the displacement fluid 46 should not mix with the active agent 38.
  • An example of a suitable displacement fluid is a grade of cured or uncured ⁇ silicone as produced by Nusil Technologies.
  • the cannula 42 is an elongate element and, as will be described below, may, in certain circumstances, be flexible to steer through passages formed in bone of the patient's body.
  • An upstream end of the cannula 42 has a mounting formation, such as a Luer lock, 48 for mounting to the outlet port 40 of the syringe 32.
  • a mounting formation such as a Luer lock
  • the cannula 42 has a plurality of axially spaced, circumferentially distributed openings 50 defined in a sidewall 52 of the cannula.
  • the mounting formation 48 is arranged at an upstream end of the sidewall 52 of the cannula.
  • Each opening 50 is closed off by an occluding device in the form of a one-way valve 54. This inhibits backflow of the agent 52 into the interior 44 of the cannula 42 after having been discharged through the relevant opening 50 of the cannula 42.
  • each opening 50 opens out into a recess 56 defined in the sidewall 52 of the cannula 42.
  • the volume of displacement fluid 46 selected equates to the volume of the interior 44 of the cannula 42.
  • the plunger 36 is withdrawn in the direction of arrow 58 (Fig. 2) after the cannula 42 has been attached to the outlet port 40 of the syringe 32. This results in a quantity of the active agent 38 being drawn into the reservoir 34 of the syringe 32 from the cannula 42 as shown in Fig. 2 of the drawings.
  • the plunger 36 When the cannula 42 has been received at the site in the patient's body, the plunger 36 is urged in the direction of arrow 60 (Fig. 4 of the drawings). This causes the active agent to be discharged through the openings 50 of the cannula 42 under the action of the displacement fluid 46 being expelled from the reservoir 34 into the interior 44 of the cannula 42.
  • the arrangement is such that substantially all of the active agent 38 has been discharged through the openings 50 of the cannula 42 and the interior 44 of the cannula 42 now contains the displacement fluid 46.
  • the one-way valves 52 inhibit backflow of the active agent 38 into the interior 44 of the cannula 42.
  • the provision of the recesses 56 facilitates discharge of the active agent 38 through the openings 50 and the likelihood of surrounding tissue inhibiting discharge of the active agent 38 is reduced.
  • the reaming tool 70 comprises a reaming head 72 which is used to form an access opening 74 and a passage 76 (Figs. 7c and 7d) in the vertebrae 12, 14 of the patient's body.
  • the reaming head 72 is a rotatable drill head mounted on an omnidirectional pivot 78.
  • the pivot 78 is, in turn, carried on a flexible shaft 80.
  • the reaming tool 70 is steerable. More particularly, the reaming head 72 is able to be steered to form curved passages (as shown, for example, in Fig. 7c of the drawings) in bone.
  • the steerability of the reaming tool 70 is provided by a steering mechanism comprising a pair of pull wires 82 mounted on opposite sides of the flexible shaft 80 to facilitate steering of the pivot 78 and, hence, the reaming head 72.
  • the vertebra 14 on which the procedure is to be performed is accessed in a minimally invasive manner.
  • a working cannula 84 is inserted percutaneously to abut against the vertebra 14.
  • the reaming tool 70 is received within the cannula 84 and is operated to form the access opening 74 and the passage 76.
  • the reaming head 72 of the tool 70 is steered through the bone of the vertebra 14 under control of the steering mechanism 82.
  • the passage 76 can extend through the intervertebral disc (not shown in Fig. 7 of the drawings) from the vertebra 14 into the vertebra 12 so that the end plates (once again, not shown in Fig. 7 of the drawings) of both vertebrae 12 and 14 can be accessed simultaneously by the cannula 42 of the system 10 subsequently inserted into the working cannula 74 as shown in Fig. 7d of the drawings.
  • Fig. 8 of the drawings various examples of cannulas 42 for use with the system 10 are shown. Hence, as shown at 90 in Fig.
  • a straight cannula 42 is used which accesses only a single vertebra of a patient's spinal column 92 in a direction parallel to a plane in which the end plate of the vertebra lies.
  • the cannula 42 is flexible and its tip 42.1 is able to be bent through a suitable angle, which may be up to approximately 90° or greater, to access the vertebra along an axis substantially perpendicular to a plane in which the end plate of the vertebra lies.
  • a single vertebra of the spinal column 92 is accessed.
  • a further example of a cannula 42 is shown.
  • the sidewall 52 of the cannula 42 is flexible and the cannula 42 is of sufficient length to enable a plurality of vertebrae of the spinal column 92 to be accessed simultaneously.
  • Reference numeral 120 shows a similar system where a longer cannula 42 is used and accesses the spinal column 92 trans-sacrally through the sacrum 94 of the spinal column 92 via an access opening 74 formed in the sacrum 94.
  • a downstream end of the cannula 42 can, from the sacrum, access all or some of the lumber vertebrae 96 of the spinal column 92.
  • the agent instead of the active agent 38 being injected directly into the bone of the vertebra, the agent can in addition, or instead, be inserted into the venous sinusoids of the vertebral bodies 12, 14.
  • the cannula 42 of the system 30 is inserted peri-annularly. This can be done by trans-sacral epidural access, transforaminal epidural access, interlaminar periannular access or, as shown in Fig. 9 of the drawings at 130, the cannula 42 can be negotiated through the epidural space 132 between the disc 16 and the spinal cord 134 of the spinal column 92. The cannula 42 is inserted from one side of the epidural space 132 to a contralateral side within the canal close to the annulus 18 of the disc 16.
  • a cannula 42 of the system 30 can be introduced into peri-annulus space 142 adjacent the annulus 18 of the disc 16.
  • Still other methods of delivering active agent may include continuous discharge of active ingredient by means of a controlled release discharge pump or a long acting deposit preparation to be implanted into the disc or adjacent vertebral bone. Through dermal patches, transcutaneous delivery of the active ingredient can be effected. Still further, the active ingredient could be taken orally together with an inactive ingredient or can be delivered parenterally.
  • Fig. 10 shows another embodiment of a distal part 144 of the receptacle in the form of the cannula 42.
  • the distal part 144 of the cannula 42 is formed of a shape memory alloy, such as, for example, Nitinol, and is pre-set into a bent shape as shown.
  • a stylet (not shown) is introduced into the interior 44 of the cannula 42 to cause the distal part 144 of the cannula 42 to straighten.
  • the stylet is removed so that the distal part 144 of the cannula 42 adopts its, pre-set, bent shape for delivery of the agent 38.
  • Fig. 11 shows a further embodiment of a distal part of the cannula 42.
  • each opening 50 is closed off by a one-way valve 54 in the form of a flap valve.
  • a flap 146 of each flap valve 54 is hinged at a leading end of its associated opening 50 to facilitate ejection of the agent 38 as shown by arrows 148.
  • Fig. 12 shows still another embodiment of a distal part of the cannula 42.
  • the cannula 42 includes an occluding device in the form of a sleeve 150 which occludes the openings 50 of the cannula during delivery of the cannula 42 to the site.
  • the sleeve 150 is withdrawn proximally in the direction of arrow 152 to expose the openings 50 and to allow the agent 38 to be discharged through the openings 50.
  • the sleeve 150 is then repositioned over the openings 50 to inhibit back-flow of the agent into the interior 44 of the cannula 42.
  • FIG. 13 and 14 still a further embodiment of a cannula 42 is shown. As is the case with the other embodiments previously described, like reference numerals refer to like parts unless otherwise specified.
  • the cannula 42 has two lumens, one defining the interior 44 of the cannula 42 and which has at least one opening 50 in communication with the interior 44.
  • a second lumen 154 runs parallel to the lumen 44 and a steering stylet 156 is contained in the lumen 154 for steering the distal part of the cannula 42 to the site and to position the distal part of the cannula 42 at the desired location at the site.
  • the occluding device 54 is, in this embodiment, an axially displaceable piston which closes off the opening 50 prior to use and is moved proximally to expose the opening 50 to allow discharge of the agent 38 at the site. It will be appreciated that the piston has a shape to permit passage of the agent 38 past it in the interior 44 of the cannula 42.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)

Abstract

L'invention porte sur un système de distribution d'agent (30) qui comprend un distributeur (32) définissant un réservoir (34) et un orifice de sortie (40) en communication avec le réservoir (34). Un fluide de déplacement biocompatible non-réactif, immiscible et de haute densité (46) est contenu à l'intérieur du réservoir (34). Un dispositif de déplacement (36) est disposé dans le réservoir (34) pour déplacer le fluide (46) à travers l'orifice de sortie (40) du distributeur (32).
PCT/AU2010/000518 2009-05-04 2010-05-04 Système de distribution d'agent WO2010127395A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17518309P 2009-05-04 2009-05-04
US61/175,183 2009-05-04

Publications (1)

Publication Number Publication Date
WO2010127395A1 true WO2010127395A1 (fr) 2010-11-11

Family

ID=43049843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2010/000518 WO2010127395A1 (fr) 2009-05-04 2010-05-04 Système de distribution d'agent

Country Status (1)

Country Link
WO (1) WO2010127395A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3030174A1 (fr) * 2013-08-05 2016-06-15 Blumenthal, Scott L. Plaque terminale vertébrale, appareil et procédé
WO2017146626A1 (fr) 2016-02-26 2017-08-31 Neuronano Ab Procédé de fourniture d'un site d'implantation dans un tissu mou

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741604A (en) * 1952-10-16 1955-12-07 S & R J Everett & Co Ltd Improvements relating to hypodermic syringes
FR2543833A1 (fr) * 1983-04-05 1984-10-12 Microtechnic Sa Ensemble non reutilisable pour l'injection d'un produit medicamentaire
US5067948A (en) * 1990-09-27 1991-11-26 Habley Medical Technology Corporation Safety, packaging, injection and disposal system for pre-filled pharmaceutical vials
US6162202A (en) * 1998-10-26 2000-12-19 Sicurelli; Robert Flexible syringe needle
US20040064088A1 (en) * 2002-09-30 2004-04-01 William Gorman Dispenser components and methods for patient infusion device
WO2005102435A1 (fr) * 2004-04-20 2005-11-03 Filippo Mastropasqua Catheter hydrodynamique apte a l'eversion
WO2005110525A2 (fr) * 2004-04-12 2005-11-24 Allergan, Inc. Systeme d'injection multi-sites
DE202005014437U1 (de) * 2005-09-13 2006-08-31 Nees, Stephan, Prof. Dr.rer.nat. Vorrichtung und Mittel zur Endothel-protektiven Perfusion von Hohlorganen mit chirurgischen Perfusionslösungen
US20080103564A1 (en) * 2005-08-17 2008-05-01 Burkinshaw Brian D Method for repairing intervertebral discs
WO2008101300A1 (fr) * 2007-02-23 2008-08-28 Cellixe Pty Ltd Composition et méthode de traitement ou de prévention de troubles rachidiens
WO2009073918A2 (fr) * 2007-12-10 2009-06-18 Cellixe Pty Ltd Dispositif de délivrance d'un agent et procédé
US20090299328A1 (en) * 2008-05-30 2009-12-03 Allergan, Inc. Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741604A (en) * 1952-10-16 1955-12-07 S & R J Everett & Co Ltd Improvements relating to hypodermic syringes
FR2543833A1 (fr) * 1983-04-05 1984-10-12 Microtechnic Sa Ensemble non reutilisable pour l'injection d'un produit medicamentaire
US5067948A (en) * 1990-09-27 1991-11-26 Habley Medical Technology Corporation Safety, packaging, injection and disposal system for pre-filled pharmaceutical vials
US6162202A (en) * 1998-10-26 2000-12-19 Sicurelli; Robert Flexible syringe needle
US20040064088A1 (en) * 2002-09-30 2004-04-01 William Gorman Dispenser components and methods for patient infusion device
WO2005110525A2 (fr) * 2004-04-12 2005-11-24 Allergan, Inc. Systeme d'injection multi-sites
WO2005102435A1 (fr) * 2004-04-20 2005-11-03 Filippo Mastropasqua Catheter hydrodynamique apte a l'eversion
US20080103564A1 (en) * 2005-08-17 2008-05-01 Burkinshaw Brian D Method for repairing intervertebral discs
DE202005014437U1 (de) * 2005-09-13 2006-08-31 Nees, Stephan, Prof. Dr.rer.nat. Vorrichtung und Mittel zur Endothel-protektiven Perfusion von Hohlorganen mit chirurgischen Perfusionslösungen
WO2008101300A1 (fr) * 2007-02-23 2008-08-28 Cellixe Pty Ltd Composition et méthode de traitement ou de prévention de troubles rachidiens
WO2009073918A2 (fr) * 2007-12-10 2009-06-18 Cellixe Pty Ltd Dispositif de délivrance d'un agent et procédé
US20090299328A1 (en) * 2008-05-30 2009-12-03 Allergan, Inc. Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Applied Silicone Corporation High Consistency Elastomer", 24 May 2010 (2010-05-24) - 27 April 2008 (2008-04-27), Retrieved from the Internet <URL:http://appliedsilicone.com/highconsistencyrubbery-platinumcure.aspx> *
"Nusil Technology: Silicones for Drug Delivery Combination Devices.", DRUG DELIVERY TECHNOLOGY, vol. 9, no. 1, January 2000 (2000-01-01), pages 50 - 51, Retrieved from the Internet <URL:http://www.drugdeliverytech-online.com/drugdelivery/200901#pg5> *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3030174A1 (fr) * 2013-08-05 2016-06-15 Blumenthal, Scott L. Plaque terminale vertébrale, appareil et procédé
EP3030174A4 (fr) * 2013-08-05 2017-04-05 Blumenthal, Scott L. Plaque terminale vertébrale, appareil et procédé
WO2017146626A1 (fr) 2016-02-26 2017-08-31 Neuronano Ab Procédé de fourniture d'un site d'implantation dans un tissu mou
CN108697887A (zh) * 2016-02-26 2018-10-23 神经毫微股份公司 在软组织中提供植入点位的方法
JP2019506249A (ja) * 2016-02-26 2019-03-07 ニューロナノ アクチェボラグ 軟組織内に埋め込み部位を提供する方法
EP3419714A4 (fr) * 2016-02-26 2019-09-25 Neuronano AB Procédé de fourniture d'un site d'implantation dans un tissu mou
JP2021074553A (ja) * 2016-02-26 2021-05-20 ニューロナノ アクチェボラグ 軟組織内に埋め込み部位を提供する方法
CN108697887B (zh) * 2016-02-26 2022-10-25 神经毫微股份公司 在软组织中提供植入点位的方法

Similar Documents

Publication Publication Date Title
US9113950B2 (en) Therapeutic delivery device
US7660634B2 (en) Combination electrical stimulating and infusion medical device
US8195307B2 (en) Combination electrical stimulating and infusion device and method
US8323277B2 (en) Combination electrical stimulating and infusion method
US8597301B2 (en) Cannula with lateral access and directional exit port
US7945331B2 (en) Combination electrical stimulating and infusion medical device and method
US7223227B2 (en) Spinal disc therapy system
US11992229B2 (en) Methods, systems, and devices for diagnosing and treating intervertebral disc degeneration
JP2010517683A (ja) 硬化性材料を骨の中に送達するための装置、システム、及び方法
US10898645B2 (en) Intervertebral dosing device and method
US20080208196A1 (en) Method and device for restoring spinal disc function
JP2007521079A (ja) 螺旋プローブ
JP2012514494A (ja) 治療用物質を椎間板に送達するための装置およびその使用方法
US20060293561A1 (en) System and methods for intervertebral disc surgery
MX2014012205A (es) Reparacion, conservacion y crecimiento de cartilago mediante la estimulacion de la zona interfacial de hueso-cartilago y sistema de suministro y metodos relacionados para los mismos.
WO2010127395A1 (fr) Système de distribution d&#39;agent
US20050273093A1 (en) Method of treating herniated intervertebral discs using cooled ablation
EP2618753B1 (fr) Cage de fusion dotée d&#39;un système combiné d&#39;administration d&#39;agents biologiques
US20070213701A1 (en) Implanting devices and methods thereof
US20220105316A1 (en) Medical delivery device and method for delivering therapeutic agents directly into the annulus fibrosus of an intervertebral disc
US20120283601A1 (en) Method and Device for Restoring Spinal Disk Functions
CN106618714A (zh) 一种用于注入骨填充材料的填充器件
WO2020219099A1 (fr) Administration d&#39;un matériau thérapeutique par l&#39;intermédiaire d&#39;un espace sous-ligamentaire
EP3749406B1 (fr) Appareils et systèmes d&#39;administration sous-mucosique de médicament
Bartoletti Innesto di tessuto cerebrale bioingegnerizzato e substrati flessibili: primi passi verso una medicina rigenerativa potenziata nell'epilessia del lobo temporale

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10771897

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 9177/DELNP/2011

Country of ref document: IN

122 Ep: pct application non-entry in european phase

Ref document number: 10771897

Country of ref document: EP

Kind code of ref document: A1